Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. World Perfumes Inc.
WARNING LETTER
•World Perfumes Inc.•May 9, 2025

World Perfumes Inc. – FDA Warning Letter, May 9, 2025

Record Details

The FDA issued a Warning Letter to World Perfumes Inc. on October 29, 2025, following an inspection of their Opa-Locka, FL drug manufacturing facility from May 5 to 9, 2025. The letter highlights significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR parts 210 and 211), deeming their drug products adulterated under the Federal Food, Drug, and Cosmetic Act.

A primary issue was the company"s failure to conduct adequate identity testing for drug product components. Specifically, World Perfumes Inc. did not test incoming ethanol for dangerous methanol contamination, nor did they ensure the alcohol met United States Pharmacopoeia (USP) specifications, even using non-pharmaceutical grade ethanol. The letter emphasizes the global lethal poisoning incidents linked to methanol-contaminated ethanol. Furthermore, the company failed to properly test high-risk ingredients, such as glycerin, for Diethylene Glycol (DEG) or Ethylene Glycol (EG) contamination, which also have a history of causing fatal poisonings.

The FDA found the company"s responses to these observations inadequate, lacking sufficient detail on how future testing would meet regulatory requirements or address the impact on products already on the market.

World Perfumes Inc. is required to undertake comprehensive actions, including an independent review of their material system, supplier qualification, and incoming material controls. They must establish robust chemical quality control specifications and detailed procedures for testing each component lot for identity, strength, quality, and purity. Critical commitments include providing methanol, DEG, and EG test results for retain samples of all components or finished drug products within 30 days.

Company
World Perfumes Inc.
Inspection date
May 9, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 7d47a6c7-325a-4bdd-8340-a823bbe238b9

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.84(d)(1)21 CFR 211.6321 CFR 211.100(a)FD&C Act 201(i)21 U.S.C. 321(i)FD&C Act 301(a)

Full citation text and observation details available on the Dashboard.

Other documents for World Perfumes Inc.
  • 483 - 2025-05-09May 9, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore World Perfumes Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.